Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · Real-Time Price · USD

1.590

+0.060 (3.92%)

At close: May 12, 2025, 4:00 PM

1.550

-0.040 (-2.52%)

After-hours: May 12, 2025, 7:14 PM EDT

Outlook Therapeutics Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2015 - 2019
Cost of Revenue	46.89	41.76	26.45	42.33	38.96	26.34	Upgrade
Gross Profit	-46.89	-41.76	-26.45	-42.33	-38.96	-26.34	Upgrade
Selling, General & Admin	36.09	29.94	26.67	20.74	12.77	9.97	Upgrade
Operating Expenses	36.09	29.94	26.67	20.74	12.77	9.97	Upgrade
Operating Income	-82.99	-71.7	-53.13	-63.07	-51.73	-36.31	Upgrade
Interest Expense	-3.16	-3.16	-2.53	-1.49	-0.94	-1.76	Upgrade
Interest & Investment Income	0.77	0.91	0.97	-	-	-	Upgrade
Earnings From Equity Investments	-0.14	-0.1	-0.01	-0.05	-0.05	-	Upgrade
Other Non Operating Income (Expenses)	41.47	1.15	0.05	0.47	-0.45	1.98	Upgrade
EBT Excluding Unusual Items	-44.04	-72.91	-54.65	-64.14	-53.16	-36.09	Upgrade
Asset Writedown	-	-	-	-	-	-0.53	Upgrade
Other Unusual Items	-2.77	-2.46	-4.33	-1.91	-	-1.9	Upgrade
Pretax Income	-46.81	-75.36	-58.98	-66.05	-53.16	-38.51	Upgrade
Income Tax Expense	0	0	0	0	0	-3.27	Upgrade
Earnings From Continuing Operations	-46.81	-75.37	-58.98	-66.05	-53.16	-35.24	Upgrade
Net Income	-46.81	-75.37	-58.98	-66.05	-53.16	-35.24	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	-	13.63	Upgrade
Net Income to Common	-46.81	-75.37	-58.98	-66.05	-53.16	-48.87	Upgrade
Shares Outstanding (Basic)	21	19	13	11	8	4	Upgrade
Shares Outstanding (Diluted)	21	19	13	11	8	4	Upgrade
Shares Change (YoY)	65.29%	48.29%	17.96%	38.91%	110.43%	298.84%	Upgrade
EPS (Basic)	-2.19	-4.06	-4.72	-6.23	-6.96	-13.47	Upgrade
EPS (Diluted)	-2.19	-4.06	-4.72	-6.23	-6.96	-13.47	Upgrade
Free Cash Flow	-66.73	-68.79	-42.97	-56.67	-54.25	-31.79	Upgrade
Free Cash Flow Per Share	-3.13	-3.71	-3.44	-5.34	-7.11	-8.76	Upgrade
EBITDA	-82.87	-71.59	-53.08	-62.87	-51.46	-35.76	Upgrade
D&A For EBITDA	0.11	0.11	0.04	0.2	0.26	0.55	Upgrade
EBIT	-82.99	-71.7	-53.13	-63.07	-51.73	-36.31	Upgrade

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q